The drug maker Dr. Reddy’s Laboratories has signed an agreement to test the Sputnik-V vaccine formulated for the corona virus in India in Russia.
Drug-maker Dr Reddy’s Laboratories has signed an agreement with Russia to trial the Sputnik-V vaccine prepared for the corona virus epidemic in Russia. Doctor Reddy’s Laboratories will issue advisory for the vaccine trial.
The Department of Biotechnology has formed the Biotechnology Industry Research Assistance Council (BIRAC) for human trials.
Dr. Reddy’s told the stock exchanges that this partnership would allow Dr. Reddy’s to identify and use some of Barak’s trial centers for vaccine trials.
Also Read: Corona virus will be rid by February 2021, government panel claims
Dr. Reddy’s earlier this month in collaboration with the Russia Direct Investment Fund (RDIF) received approval from the Controller General of Indian Drugs (DCGI) for the trial of Sputnik-V vaccines in India.
Cyber attack on Dr. Reddy
Let me tell you that some time ago, Dr. Reddy’s had to stop the services of all his data centers around the world. It was said that there was a cyber attack on the company. Due to which the service of this data centers had to be stopped.
We have taken all measures to ensure that the information provided in this article and on our social media platform is credible, verified and sourced from other Big media Houses. For any feedback or complaint, reach out to us at businessleaguein@gmail.com
